BRISBANE, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that the primary endpoint was met in the ORIGIN Phase 3 trial of atacicept for the treatment of immunoglobulin A nephropathy (IgAN) in adults.

MORRISVILLE, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that Liquidia is scheduled to make its first commercial shipment of YUTREPIA™ (treprostinil) inhalation powder, marking the first time YUTREPIA will be available to be prescribed to patients at specialty pharmacies. This milestone was achieved only five business days following the U.S. Food and Drug Administration (FDA) approval of YUTREPIA on May 23, 2025, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Proceeds to Support Company's Strategic Focus on Data Center Business Proceeds to Support Company's Strategic Focus on Data Center Business

NEW YORK--(BUSINESS WIRE)---- $LZM #BatteryMetals--Lifezone Metals Limited's (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE:CTRE) (“CareTrust” or the “Company”) announced today that, together with a joint venture partner, it has acquired a portfolio of skilled nursing facilities located in the Pacific Northwest for a total purchase price of approximately $146 million, inclusive of transaction costs. The portfolio consists of 10 facilities comprising 911 licensed beds located across Idaho, Oregon and Washington. The acquisition was completed through a.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE:CTRE) (“CareTrust”) announced today the closing of a new senior unsecured term loan and the hiring of two talented real estate professionals. These actions further bolster its growth platform and strengthen the Company's long-term prospects at a time of accelerating investment in its healthcare portfolio. New Term Loan The Company closed on an amendment to its existing credit agreement with KeyBank National Association and a synd.

VICTOR, N.Y.--(BUSINESS WIRE)--Broadstone Net Lease, Inc. (NYSE: BNL) (“Broadstone,” “BNL,” the “Company,” “we,” “our,” or “us”), today provided an update on its recent business activity through June 2, 2025. Additionally, the Company announced that BNL's CEO, John Moragne and CFO, Kevin Fennell, will be participating in the Nareit REITweek 2025 Annual Conference in New York, NY on June 3 and June 4, 2025. JUNE 2025 BUSINESS UPDATE Quarter-to-date, we have invested $83.3 million, including $54.

CHICAGO & NEW YORK--(BUSINESS WIRE)--Antares Capital and Ares Management Corporation (“Ares”) (NYSE: ARES) today announced the closing of Antares' first continuation vehicle with over $1.2 billion in commitments. The transaction was led by Ares Credit Secondaries funds, along with a commitment from Antares. The continuation vehicle was established to purchase assets and limited partner interests from two comingled private credit funds comprising over 100 underlying first lien, floating rate loa.

TierneyMJ / Shutterstock.com Realty Income If you're looking for a stock that pays monthly dividends, Realty Income Corporation (NYSE: O) is a top monthly dividend company.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151208&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

Stoneridge is a small-cap, global automotive electronics supplier trading at attractive valuations versus peers, despite recent revenue volatility and net losses. Management projects significant growth, targeting $1.3–$1.45 billion revenue and $160–$200 million EBITDA by 2029, driven by products like MirrorEye. Even with near-term sales weakness and tariff risks, most revenue is USMCA-exempt and management is actively mitigating trade impacts.

Kaufman Kapital exercises warrant and extends key debt maturities, providing $1 million in support of BranchOut's financial strategy Bend, OR, June 2, 2025 – PRISM MediaWire – BranchOut Food Inc.

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious Fortune 500 list for the first time since becoming a fully independent company. With 2024 full year sales of $15.5 billion, Kenvue is listed at number 281. The company's debut is a testament to the power of its iconic brands and deep commitment to improving the health and well-being of consumers globally through science.

BranchOut Food Inc. Announces Plan to Eliminate Current Liability Notes Payable with $1 Million Warrant Exercise and Extension of Key Financing Agreements

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151200&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that it is commencing an underwritten public offering of pre-funded warrants to purchase shares of common stock accompanied by Series A warrants to purchase shares of common stock (or, in certain circumstances, pre-funded warrants), Series B warrants to purchase shares of common stock (or, in certain circumstances, pre-funded warrants) and Series C warrants to purchase shares of common stock (or, in certain circumstances, pre-funded warrants). All of the securities to …

LOS ANGELES , June 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the federal securities laws. Shareholders who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.

Q3 EPS seen down 13% YoY despite Sovos-driven revenue growth and Rao's volume strength Snacks weakness and increased A&C spend pressure EBIT margin into guidance reset window Organic sales still trending negative as Campbell's faces mix and price realization headwinds Are you ahead, or behind on retirement?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151207&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

MURFREESBORO, TN / ACCESS Newswire / June 2, 2025 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor presentation which can be found at: https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx The presentation updates NHI's investment pipeline to approximately $331.4 million that includes $126.7 million in signed LOI's of which approximately $71 million represents a SHOP investment. About NHI Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.